NCT03548701View on ClinicalTrials.gov

Thromboelastometry Prediction Utility for Risk of Abortion

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Pregnancy Trimester, FirstAbortion, Threatened
Interventions
DIAGNOSTIC_TEST

Thromboelastometry testing

Thromboelastometry testing - a form of testing in whole blood for coagulation abnormalities

Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03548701 - Thromboelastometry Prediction Utility for Risk of Abortion | Biotech Hunter | Biotech Hunter